SAMD9L acts as an antiviral factor against HIV-1 and primate lentiviruses by restricting viral and cellular translation

QH301-705.5 Tumor Suppressor Proteins Lentiviruses, Primate Intracellular Signaling Peptides and Proteins 610 HIV Infections Virus Replication [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity Antiviral Restriction Factors HEK293 Cells [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases Protein Biosynthesis [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology HIV-1 Humans Animals Biology (General) Research Article
DOI: 10.1371/journal.pbio.3002696 Publication Date: 2024-07-03T17:22:50Z
ABSTRACT
Sterile alpha motif domain-containing proteins 9 and 9-like (SAMD9/9L) are associated with life-threatening genetic diseases in humans restriction factors of poxviruses. Yet, their cellular function the extent antiviral role poorly known. Here, we found that interferon-stimulated human SAMD9L restricts HIV-1 late phases replication, at posttranscriptional prematuration steps, impacting viral translation and, possibly, endosomal trafficking. Surprisingly, paralog SAMD9 exerted an opposite effect, enhancing HIV-1. More broadly, showed primate lentiviruses, but not a gammaretrovirus (MLV), nor 2 RNA viruses (arenavirus MOPV rhabdovirus VSV). Using structural modeling mutagenesis SAMD9L, identified conserved Schlafen-like active site necessary for by rodent SAMD9L. By testing gain-of-function constitutively variant from patients SAMD9L-associated autoinflammatory disease, determined pathogenic functions also depend on site. Finally, strongly inhibited HIV, MLV, to lesser extent, MOPV. This suggests virus-specific effect may involve its differential activation/sensing virus ability evade restriction. Overall, our study identifies as factor cell autonomous immunity deciphers host determinants underlying translational repression. provides novel links therapeutic avenues against infections diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (2)